Clinical Trial Update: Study of Allogeneic Anti-PSMA CAR-NK Cell for Metastatic Castration-Resistant Prostate Cancer [EARLY_Phase 1]

View source ↗

Summary

Early-phase clinical trial evaluating allogeneic anti-PSMA CAR-NK cells for metastatic castration-resistant prostate cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Allogeneic anti-PSMA CAR-NK cell

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Prostate Cancer Castration-resistant Prostate Cancer | EARLY_Phase 1 | Status: RECRUITING